Benefits
Antioxidant defense
The only human study cited here tested Activin, a different company's grape seed proanthocyanidin extract, not FitGrape. It was done in people with systemic sclerosis, a rare autoimmune connective-tissue disease, and it reported lower blood levels of malondialdehyde (an oxidative-stress marker) and of the adhesion molecules ICAM-1, VCAM-1, E-selectin and P-selectin. Those are laboratory markers, not symptoms or health outcomes, and nothing here shows what FitGrape does in a healthy person.
Blood-vessel effects are unproven
This is a proposed idea, not something the Activin study measured; pooled grape seed extract trials found no significant change in flow-mediated dilation, a test of vessel relaxation. That study looked at adhesion molecules in the blood, which are markers researchers track in vessel biology. It did not measure blood flow, blood pressure or any circulation outcome, and it did not test FitGrape.
Cell protection (laboratory finding only)
Grape OPCs act as antioxidants in laboratory tests. Whether taking FitGrape protects cells or tissues in people has not been tested.
Slightly lower diastolic blood pressure in grape seed extract trials
Studied as generic grape seed extract, not FitGrape, and FitGrape's grape source is not stated. A pooled analysis of 19 controlled trials found diastolic pressure 2.2 mmHg and heart rate 1.25 beats per minute lower than controls, but no significant change in systolic pressure or vessel dilation, with very high variation between trials. An earlier pooled analysis of 16 trials (810 people) reported larger drops.
Mechanism of action
Proanthocyanidin antioxidants
Grape OPCs can neutralize free radicals in laboratory tests, and researchers think they may help the body's own antioxidant enzymes. This is the proposed explanation for how they might work. It has not been confirmed for FitGrape in people.
Vascular signaling
Grape polyphenols are thought to influence nitric oxide, a signal that helps blood vessels relax. This is a theory drawn from other grape research, not something the Activin study cited on this page measured.
Clinical trials
A 2002 study of Activin, a grape seed proanthocyanidin extract made by a different company. It is not a study of FitGrape. It measured blood markers of oxidative stress and adhesion molecules. (Kalin et al. 2002, Free Radical Research)
People with systemic sclerosis (scleroderma), a rare autoimmune connective-tissue disease. Not healthy adults.
The extract lowered blood levels of malondialdehyde (an oxidative-stress marker) and of the adhesion molecules ICAM-1, VCAM-1, E-selectin and P-selectin. These are surrogate laboratory markers. The study did not report symptom or clinical outcomes, and the results belong to Activin, not to FitGrape.